BNCT pancreatic cancer treatment strategy with glucose-conjugated boron drug.
Fujimoto T, Teraishi F, Kanehira N, Tajima T, Sakurai Y, Kondo N, Yamagami M, Kuwada A, Morihara A, Kitamatsu M, Fujimura A, Suzuki M, Takaguchi Y, Shigeyasu K, Fujiwara T, Michiue H.
Fujimoto T, et al. Among authors: yamagami m.
Biomaterials. 2024 May 9;309:122605. doi: 10.1016/j.biomaterials.2024.122605. Online ahead of print.
Biomaterials. 2024.
PMID: 38754291